Actinium Pharmaceuticals, Inc. (ATNM)
1.45
+0.02
(+1.40%)
USD |
NYAM |
Dec 10, 16:00
1.45
0.00 (0.00%)
After-Hours: 17:14
Actinium Pharmaceuticals Profit Margin (Quarterly): -5.70K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arcus Biosciences, Inc. | -519.2% |
| Apyx Medical Corp. | -15.18% |
| AbbVie, Inc. | 1.13% |
| Karyopharm Therapeutics, Inc. | -75.21% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -133.6% |
| Return on Assets | -49.88% |
| Return on Invested Capital | -126.6% |
| Gross Profit Margin (Quarterly) | -128.9% |
| Operating Margin (Quarterly) | -6.32K% |
| Return on Net Operating Assets | -1.64K% |